SLC5A2 and pulmonary tuberculosis: Pulmonary tuberculosis: We found a mediated effect of SGLT2 inhibition on pulmonary tuberculosis through the involvement of the genus Phascolarctobacterium id.2168 (OR: 0.170, 95% CI: 0.123–0.236, P = 1.57×10-26).